Fig. 5From: Uncovering the Fate and Risks of Intravenously Injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics, and MetabolomicsProteomics and metabolomics analysis of mouse livers after i.v. administration of 20Â mg/kg PB NPs. (a) Venn diagram of differentially expressed proteins in the liver. (blue: 7th day, pink: 60th day) (b) KEGG pathway enrichment analysis of differentially expressed proteins in the livers on the 7th day. (c) OPLS-DA score plot of the liver metabolome. (d) Venn diagram of changed metabolites in the livers (blue: 7th day, pink: 60th day). (e-f) KEGG pathway enrichment analysis of the changed metabolites in the livers on the 7th day (e) and the 60th day (f)Back to article page